v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (242,974) $ (258,226)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 39,044 32,902
Deferred income taxes (2,687) (2,625)
Equity in net loss of equity-method investees 327 1,709
Stock-based compensation, net 4,192 9,422
Goodwill impairment 150,926 201,518
Intangibles and long-lived asset impairment 26,964 42,029
Loss on sale of assets 48,501 2,202
Other non-cash items, net 2,871 773
Increase (decrease) in cash attributable to changes in operating assets and liabilities:    
Accounts receivable 17,641 (1,361)
Inventories 59,556 (10,605)
Other current assets (39,769) (8,279)
Other assets and liabilities (4,009) (561)
Accounts payable and accrued expenses 6,243 15,865
Net cash provided by operating activities 66,826 24,763
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property, plant and equipment (16,004) (19,060)
Proceeds from sale of assets 102,770 13,773
Investments and joint ventures, net 0 2,570
Proceeds from termination of net investment hedges 0 2,363
Net cash provided by (used in) investing activities 86,766 (354)
CASH FLOWS FROM FINANCING ACTIVITIES    
Borrowings under bank revolving credit facility 156,000 156,000
Repayments under bank revolving credit facility (205,500) (186,000)
Repayments under term loan (106,725) (5,625)
Payments of other debt, net (2,642) (21)
Employee shares withheld for taxes (343) (1,381)
Proceeds from termination of fair value hedge 0 552
Net cash used in financing activities (159,210) (36,475)
Effect of exchange rate changes on cash (4,426) 2,184
Net decrease in cash and cash equivalents (10,044) (9,882)
Cash and cash equivalents at beginning of period 54,355 54,307
Cash and cash equivalents at end of period $ 44,311 $ 44,425